全文获取类型
收费全文 | 347篇 |
免费 | 43篇 |
出版年
2021年 | 5篇 |
2019年 | 4篇 |
2018年 | 3篇 |
2017年 | 9篇 |
2016年 | 17篇 |
2015年 | 19篇 |
2014年 | 23篇 |
2013年 | 19篇 |
2012年 | 23篇 |
2011年 | 21篇 |
2010年 | 28篇 |
2009年 | 15篇 |
2008年 | 11篇 |
2007年 | 13篇 |
2006年 | 26篇 |
2005年 | 8篇 |
2004年 | 19篇 |
2003年 | 10篇 |
2002年 | 13篇 |
2001年 | 10篇 |
2000年 | 11篇 |
1999年 | 5篇 |
1998年 | 2篇 |
1997年 | 2篇 |
1996年 | 4篇 |
1995年 | 5篇 |
1993年 | 2篇 |
1992年 | 3篇 |
1991年 | 4篇 |
1990年 | 7篇 |
1989年 | 5篇 |
1988年 | 3篇 |
1987年 | 2篇 |
1985年 | 3篇 |
1984年 | 3篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1975年 | 4篇 |
1974年 | 4篇 |
1972年 | 2篇 |
1971年 | 2篇 |
1969年 | 2篇 |
1968年 | 2篇 |
1967年 | 1篇 |
1965年 | 2篇 |
1964年 | 2篇 |
1960年 | 2篇 |
1951年 | 1篇 |
1949年 | 1篇 |
1926年 | 1篇 |
排序方式: 共有390条查询结果,搜索用时 20 毫秒
11.
12.
Martijn F Schenk Jan HG Cordewener Antoine HP America Wendy PC van't Westende Marinus JM Smulders Luud JWJ Gilissen 《BMC plant biology》2009,9(1):24
Background
Bet v 1 is an important cause of hay fever in northern Europe. Bet v 1 isoforms from the European white birch (Betula pendula) have been investigated extensively, but the allergenic potency of other birch species is unknown. The presence of Bet v 1 and closely related PR-10 genes in the genome was established by amplification and sequencing of alleles from eight birch species that represent the four subgenera within the genus Betula. Q-TOF LC-MSE was applied to identify which PR-10/Bet v 1 genes are actually expressed in pollen and to determine the relative abundances of individual isoforms in the pollen proteome. 相似文献13.
14.
15.
Sanne R. Martens-de Kemp Arjen Brink Marijke Stigter-van Walsum J. Mirjam A. Damen François Rustenburg Thijs Wu Wessel N. van Wieringen Gerrit Jan Schuurhuis Boudewijn J.M. Braakhuis Monique Slijper Ruud H. Brakenhoff 《Stem cell research》2013,10(3):477-488
Patients with advanced head and neck squamous cell carcinomas (HNSCCs) are often treated with concomitant chemotherapy and radiotherapy, but only 50% is cured. A possible explanation for treatment failure is therapy resistance of the cancer stem cells (CSCs). The application of compounds specifically targeting these CSCs, in addition to routinely used therapeutics, would likely improve clinical outcome. We demonstrate that the previously described monoclonal antibody K984 recognizes the CD98 cell surface protein, which is specifically expressed by cells forming the squamous basal cell layer, the region where the squamous stem cells reside. Moreover, CD98 is highly resistant to the proteolytic enzymes required for CSC enrichment procedures. We show that CD98high cells, in contrast to CD98low cells, are able to generate tumors in immunodeficient mice, indicating that CD98high cells have stem cell characteristics. Furthermore, the CD98high subpopulation expresses high levels of cell cycle control and DNA repair genes, while the CD98low fraction shows expression patterns that represent the more differentiated cells forming the bulk of the tumor. CD98 is a promising CSC enrichment marker in HNSCC. Our data support the CSC concept in head and neck cancer and the potential relevance of these cells for treatment outcome. 相似文献
16.
Anton Orlin Dolan Sondhi Matthew T. Witmer Matthew M. Wessel Jason G. Mezey Stephen M. Kaminsky Neil R. Hackett Kaleb Yohay Barry Kosofsky Mark M. Souweidane Michael G. Kaplitt Donald J. D’Amico Ronald G. Crystal Szilárd Kiss 《PloS one》2013,8(8)
Background
Late infantile neuronal ceroid lipofuscinosis (LINCL), one form of Batten’s disease is a progressive neurodegenerative disorder resulting from a CLN2 gene mutation. The spectrum of ophthalmic manifestations of LINCL and the relationship with neurological function has not been previously described.Methods
Patients underwent ophthalmic evaluations, including anterior segment and dilated exams, optical coherence tomography, fluorescein and indocyanine green angiography. Patients were also assessed with the LINCL Neurological Severity Scale. Ophthalmic findings were categorized into one of five severity scores, and the association of the extent of ocular disease with neurological function was assessed.Results
Fifty eyes of 25 patients were included. The mean age at the time of exam was 4.9 years (range 2.5 to 8.1). The mean ophthalmic severity score was 2.6 (range 1 to 5). The mean neurological severity score was 6.1 (range 2 to 11). Significantly more severe ophthalmic manifestations were observed among older patients (p<0.005) and patients with more severe neurological findings (p<0.03). A direct correlation was found between the Ophthalmic Severity Scale and the Weill Cornell Neurological Scale (p<0.002). A direct association was also found between age and the ophthalmic manifestations (p<0.0002), with older children having more severe ophthalmic manifestations.Conclusions
Ophthalmic manifestations of LINCL correlate closely with the degree of neurological function and the age of the patient. The newly established LINCL Ophthalmic Scale may serve as an objective marker of LINCL severity and disease progression, and may be valuable in the evaluation of novel therapeutic strategies for LINCL, including gene therapy. 相似文献17.
Diversity in the fertilization envelopes of echinoderms 总被引:1,自引:0,他引:1
18.
19.
Bjarne Brudeli Kjetil Wessel Andressen Lise Román Moltzau Nils Olav Nilsen Finn Olav Levy Jo Klaveness 《Bioorganic & medicinal chemistry》2013,21(22):7134-7145
Serotonin (5-hydroxytryptamine, 5-HT) is an important signaling molecule in the central nervous system (CNS) and in non-neuronal tissues and organs. Serotonin mediates a positive chronotropic and inotropic response through 5-HT4 receptors in the atrium and ventricle of the heart. Recent investigations have revealed increased expression of the 5-HT4(b) isoform in cardiomyocytes of chronic arrhythmic and failing hearts, and that the use of 5-HT4 receptor antagonists may be beneficial for treating these conditions. The 5-HT4 receptor possesses a transmembrane (TM) binding site important for ligand affinity and recognition, as well as a capacity to accommodate bulky ligands. A new series of peripherally-acting 5-HT4 receptor antagonists were prepared by combining the acidic biphenyl group from the class of angiotensin II receptor blockers (ARBs) with the SB207266 (piboserod) scaffold. The new compounds were pharmacologically evaluated and carboxylic acid 21 was identified as a potent and promising 5-HT4 receptor antagonist with moderate affinity for the AT1 receptor. The permeability of carboxylic acid 21 in a Caco-2 assay was low and the corresponding prodrug esters 23a–f were therefore prepared. The pharmacokinetics of methyl ester 20 and n-butyl ester 23c were evaluated in a rat model, revealing incomplete metabolism to carboxylic acid 21. However, methyl ester 20 is a potent 5-HT4 receptor antagonist with binding affinities in the low picomolar range. Methyl ester 20 has promising oral bioavailability and pharmacokinetics and may target 5-HT4 receptors in both CNS and peripheral organs. 相似文献
20.